510(k) K060853
K060853 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Corp. for the device "ONLINE TDM TOBRAMYCIN". The FDA issued a decision of Substantially Equivalent on June 9, 2006. The device falls under product code KLB (Radioimmunoassay, Tobramycin), a Class II device regulated under 21 CFR 862.3900. Roche Diagnostics Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 9, 2006
- Date Received
- March 29, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Tobramycin
- Device Class
- Class II
- Regulation Number
- 862.3900
- Review Panel
- TX
- Submission Type